SINOMAB BIO-B: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: COMPLETION OF CERTAIN SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: GRANT OF SHARE OPTIONS
SINOMAB BIO-B: GRANT OF SHARE OPTIONS
SINOMAB BIO-B: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: GRANT OF SHARE OPTIONS
SINOMAB BIO-B: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: PROPOSAL FOR ADOPTION OF THE 2022 SHARE OPTION SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETING
SINOMAB BIO-B: PROPOSED ADOPTION OF SHARE OPTION SCHEME
SINOMAB BIO-B: PROPOSAL FOR ADOPTION OF THE 2022 SHARE OPTION SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETING
SINOMAB BIO-B: LAPSE OF PROPOSED ISSUE OF HK$100,000,000 CONVERTIBLE BONDS
SINOMAB BIO-B: (1) CONNECTED TRANSACTION - PROPOSED ISSUE OF HK$100,000,000 CONVERTIBLE BONDS DUE 2022 POSSIBLE ISSUE OF SHARES UNDER SPECIFIC MANDATE AND (2) NOTICE OF EGM
SINOMAB BIO-B: DELAY IN DESPATCH OF CIRCULAR
SINOMAB BIO-B: CONNECTED TRANSACTION - PROPOSED ISSUE OF HK$100,000,000 CONVERTIBLE BONDS DUE 2022 POSSIBLE ISSUE OF SHARES UNDER SPECIFIC MANDATE
SINOMAB BIO-B: INSIDE INFORMATION - SHARES DEALING BY A SUBSTANTIAL SHAREHOLDER
SINOMAB BIO-B: CHANGES IN SHAREHOLDING OF CONTROLLING SHAREHOLDERS
SINOMAB BIO-B: CHANGES IN SHAREHOLDING OF CONTROLLING SHAREHOLDERS
SINOMAB BIO-B: Green Application Form
No Data